Helius Medical Technologies Investor Relations Material

Helius Medical Technologies Inc. is a neurotechnology company focused on developing non-invasive treatments for neurological conditions. The company’s primary product, the Portable Neuromodulation Stimulator (PoNS), is designed to help improve balance and gait in patients with neurological diseases or trauma, such as multiple sclerosis and traumatic brain injury. The PoNS® device stimulates the brain through the tongue, promoting neuroplasticity and aiding in physical rehabilitation. Helius Medical Technologies aims to offer innovative therapeutic solutions to enhance the quality of life for individuals with neurological impairments. The company is headquartered in Newtown, Pennsylvania, and its shares are listed on the NASDAQ.